OABI Q4 2024 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M+124.1% YoY

Gross Profit

$11M100.0% margin

Operating Income

-$16M-147.0% margin

Net Income

-$13M-121.0% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

+159.0%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$326M

Total Liabilities

$38M

Stockholders' Equity

$288M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$5M	+124.1%
Gross Profit	$11M	$5M	+124.1%
Operating Income	-$16M	-$21M	+25.1%
Net Income	-$13M	-$14M	+7.0%

Revenue Segments

Service

$9M97%

Royalty

$258,0003%